Dallas, Texas, Aug. 10, 2017 -- Dr. Lori Stetler and Dr. Kristel Polder, of Dallas Center for Dermatology and Aesthetics, are among the first doctors in Dallas to perform upper arm fat reduction treatment with CoolSculpting, the first and only FDA-cleared technology to address this area of the body. 2
CoolSculpting works by gently cooling targeted fat cells in the body and producing a natural, controlled elimination of these fat cells without affecting surrounding tissue. While CoolSculpting has been used to treat other areas of the body, the recent FDA clearance of its CoolAdvantage™ Petite Applicator makes it the only non-invasive fat removal technology available in the U.S. to address upper arm fat.
“We’ve had a waiting list for months of patients who are ready to say goodbye to their ‘bat wings’,” says Dr. Polder. “Since we offer dual sculpting, we can treat both arms at the same time, and schedule patients for one session that only lasts 35 minutes.”
CoolSculpting is a safe and effective treatment for non-invasive fat reduction. The technology is FDA-cleared for the treatment of fat bulges in the submental (below the chin) area, thigh, abdomen, flank, bra and back fat area, underneath the buttocks and now, the upper arm.
Dr. Stetler explains that CoolSculpting is not a weight-loss treatment. “Each contouring treatment reduces about 20 to 25% of fat cells in the targeted area, and most people require two sessions to achieve their desired results,” says Dr. Stetler. “CoolSculpting is most effective for stubborn pockets of fat that just won’t go away with routine exercise and maintaining a healthy diet.”
Only a select group of dermatologists currently have access to the CoolAdvantage™ Petite Applicator, with a more expanded launch to follow in the coming weeks. CoolSculpting® is developed and marketed by ZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ).
About the Dallas Center for Dermatology and Aesthetics
The Dallas Center for Dermatology and Aesthetics, founded in 1991, is located in the Park Cities area of the metropolitan community. Dr. Lori Stetler and Dr. Kristel Polder are board-certified dermatologists, clinical professors, and skin care experts specializing in general medical and cosmetic dermatology, laser procedures, facial rejuvenation, injectables, and non-surgical body contouring.
For more information, please contact:
Suzie Robinson, APR
Atria Public Relations
[email protected] | 214-577-9329
1.) FDA - https://www.accessdata.fda.gov/cdrh_docs/pdf16/K162050.pdf
2.) .CoolSculpting® Announces Only FDA-Cleared Non-Invasive Treatment for Upper Arm Fat - https://globenewswire.com/news-release/2017/01/26/911210/0/en/CoolSculpting-Announces-Only-FDA-Cleared-Non-Invasive-Treatment-for-Upper-Arm-Fat.html
Suzie Robinson The Dallas Center for Dermatology and Aesthetics, 214-5779329 [email protected]


Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion 



